Bio-Techne (TECH) Competitors $72.41 -0.76 (-1.04%) (As of 11:22 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends TECH vs. A, MTD, ILMN, WAT, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Bio-Techne stock or one of its competitors? The main competitors of Bio-Techne include Agilent Technologies (A), Mettler-Toledo International (MTD), Illumina (ILMN), Waters (WAT), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Bio-Techne vs. Agilent Technologies Mettler-Toledo International Illumina Waters Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Bio-Techne (NASDAQ:TECH) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends, community ranking and profitability. Which has higher earnings and valuation, TECH or A? Agilent Technologies has higher revenue and earnings than Bio-Techne. Agilent Technologies is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Techne$1.17B9.92$168.10M$0.9477.84Agilent Technologies$6.51B5.94$1.29B$4.4230.43 Which has more volatility and risk, TECH or A? Bio-Techne has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Is TECH or A more profitable? Agilent Technologies has a net margin of 19.80% compared to Bio-Techne's net margin of 12.86%. Agilent Technologies' return on equity of 25.43% beat Bio-Techne's return on equity.Company Net Margins Return on Equity Return on Assets Bio-Techne12.86% 12.76% 9.59% Agilent Technologies 19.80%25.43%13.79% Do analysts rate TECH or A? Bio-Techne presently has a consensus target price of $82.00, suggesting a potential upside of 12.07%. Agilent Technologies has a consensus target price of $143.62, suggesting a potential upside of 6.77%. Given Bio-Techne's stronger consensus rating and higher possible upside, equities analysts clearly believe Bio-Techne is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Techne 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.63Agilent Technologies 1 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.43 Does the media prefer TECH or A? In the previous week, Agilent Technologies had 11 more articles in the media than Bio-Techne. MarketBeat recorded 22 mentions for Agilent Technologies and 11 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 0.75 beat Agilent Technologies' score of 0.46 indicating that Bio-Techne is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Techne 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 7 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals believe in TECH or A? 98.9% of Bio-Techne shares are owned by institutional investors. Comparatively, 87.4% of Agilent Technologies shares are owned by institutional investors. 3.9% of Bio-Techne shares are owned by company insiders. Comparatively, 0.3% of Agilent Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is TECH or A a better dividend stock? Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.4%. Agilent Technologies pays an annual dividend of $0.99 per share and has a dividend yield of 0.7%. Bio-Techne pays out 34.0% of its earnings in the form of a dividend. Agilent Technologies pays out 22.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies is clearly the better dividend stock, given its higher yield and lower payout ratio. Does the MarketBeat Community believe in TECH or A? Agilent Technologies received 469 more outperform votes than Bio-Techne when rated by MarketBeat users. Likewise, 71.09% of users gave Agilent Technologies an outperform vote while only 62.64% of users gave Bio-Techne an outperform vote. CompanyUnderperformOutperformBio-TechneOutperform Votes39462.64% Underperform Votes23537.36% Agilent TechnologiesOutperform Votes86371.09% Underperform Votes35128.91% SummaryAgilent Technologies beats Bio-Techne on 12 of the 20 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECH vs. The Competition Export to ExcelMetricBio-TechneBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.63B$2.94B$5.15B$9.08BDividend Yield0.43%1.90%5.12%4.25%P/E Ratio77.8446.7386.7717.18Price / Sales9.92415.061,119.55117.12Price / Cash32.71182.1043.2337.85Price / Book5.573.894.784.78Net Income$168.10M-$42.21M$120.55M$225.60M7 Day Performance-3.93%-2.36%-1.48%-1.36%1 Month Performance2.65%1.83%13.95%0.20%1 Year Performance-5.61%16.78%28.80%15.30% Bio-Techne Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECHBio-Techne4.6302 of 5 stars$72.41-1.0%$82.00+13.2%-5.6%$11.51B$1.17B77.033,100Positive NewsAAgilent Technologies4.7312 of 5 stars$137.91-0.8%$143.62+4.1%-3.6%$39.63B$6.51B31.4518,100Analyst RevisionMTDMettler-Toledo International3.8165 of 5 stars$1,267.86-0.7%$1,351.25+6.6%+1.4%$26.76B$3.76B34.4317,300ILMNIllumina4.359 of 5 stars$143.47-0.3%$165.95+15.7%-2.8%$22.75B$4.39B-14.449,300WATWaters3.7216 of 5 stars$375.89-0.6%$375.850.0%+11.7%$22.32B$2.91B36.097,900Analyst ForecastCRLCharles River Laboratories International4.455 of 5 stars$191.47+0.5%$214.00+11.8%-21.4%$9.79B$4.06B23.8421,800BIOBio-Rad Laboratories4.3456 of 5 stars$339.53+1.0%$394.20+16.1%+2.1%$9.51B$2.58B-12.308,030Analyst RevisionPositive NewsBRKRBruker4.9926 of 5 stars$57.37-0.6%$74.70+30.2%-22.7%$8.70B$2.96B27.759,707PACBPacific Biosciences of California1.545 of 5 stars$2.03+3.6%$2.95+45.5%-80.4%$555.94M$200.52M-1.46730HBIOHarvard Bioscience1.2769 of 5 stars$2.11-2.3%N/A-60.9%$92.03M$97.73M-6.55490TMOThermo Fisher Scientific4.9458 of 5 stars$533.07+1.2%$652.30+22.4%-1.0%$203.90B$42.86B33.03122,000 Related Companies and Tools Related Companies A Competitors MTD Competitors ILMN Competitors WAT Competitors CRL Competitors BIO Competitors BRKR Competitors PACB Competitors HBIO Competitors TMO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TECH) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Techne Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Techne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
